Thomas Buchholz
Director/Miembro de la Junta en Nucleix Ltd. .
Cargos activos de Thomas Buchholz
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Nucleix Ltd.
 Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Director/Miembro de la Junta | 11/05/2020 | - |
Historial de carrera de Thomas Buchholz
Formación de Thomas Buchholz.
| Tufts University School of Medicine | Doctorate Degree |
| Bucknell University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 3 |
| Israel | 2 |
Operativa
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
| Director/Board Member | 1 |
Sectorial
| Consumer Services | 3 |
| Health Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Nucleix Ltd.
Nucleix Ltd. Medical/Nursing ServicesHealth Services Nucleix Ltd. develops, manufactures and markets non-invasive molecular cancer diagnostic tests. Its product Bladder EpiCheck is a urine test for monitoring of bladder cancer. The firm provides diagnostic tests for lung and colorectal cancer detection from blood samples, using its proprietary and highly innovative technology. The company was founded by Adam Wasserstrom, Dan Frumkin, and Elon A. Ganor in 2008 and is headquartered in Rehovot, Israel. | Health Services |
- Bolsa de valores
- Insiders
- Thomas Buchholz
- Experiencia
